BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17497678)

  • 1. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency.
    Maruyama Z; Yoshida CA; Furuichi T; Amizuka N; Ito M; Fukuyama R; Miyazaki T; Kitaura H; Nakamura K; Fujita T; Kanatani N; Moriishi T; Yamana K; Liu W; Kawaguchi H; Nakamura K; Komori T
    Dev Dyn; 2007 Jul; 236(7):1876-90. PubMed ID: 17497678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of bone development and extracellular matrix protein genes by RUNX2.
    Komori T
    Cell Tissue Res; 2010 Jan; 339(1):189-95. PubMed ID: 19649655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
    Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
    J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cbf beta regulates Runx2 function isoform-dependently in postnatal bone development.
    Kanatani N; Fujita T; Fukuyama R; Liu W; Yoshida CA; Moriishi T; Yamana K; Miyazaki T; Toyosawa S; Komori T
    Dev Biol; 2006 Aug; 296(1):48-61. PubMed ID: 16797526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation.
    Kwun IS; Cho YE; Lomeda RA; Shin HI; Choi JY; Kang YH; Beattie JH
    Bone; 2010 Mar; 46(3):732-41. PubMed ID: 19913120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requisite roles of Runx2 and Cbfb in skeletal development.
    Komori T
    J Bone Miner Metab; 2003; 21(4):193-7. PubMed ID: 12811622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc-finger transcription factor odd-skipped related 2 is one of the regulators in osteoblast proliferation and bone formation.
    Kawai S; Yamauchi M; Wakisaka S; Ooshima T; Amano A
    J Bone Miner Res; 2007 Sep; 22(9):1362-72. PubMed ID: 17547533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts.
    Zimmerman D; Jin F; Leboy P; Hardy S; Damsky C
    Dev Biol; 2000 Apr; 220(1):2-15. PubMed ID: 10720426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of bone development and maintenance by Runx2.
    Komori T
    Front Biosci; 2008 Jan; 13():898-903. PubMed ID: 17981598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated transfer of siRNA against Runx2/Cbfa1 inhibits the formation of heterotopic ossification in animal model.
    Lin L; Chen L; Wang H; Wei X; Fu X; Zhang J; Ma K; Zhou C; Yu C
    Biochem Biophys Res Commun; 2006 Oct; 349(2):564-72. PubMed ID: 16949041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletogenesis in Xenopus tropicalis: characteristic bone development in an anuran amphibian.
    Miura S; Hanaoka K; Togashi S
    Bone; 2008 Nov; 43(5):901-9. PubMed ID: 18692165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose estrogen-induced osteogenesis is decreased in aged RUNX2(+/-) mice.
    Jüttner KV; Perry MJ
    Bone; 2007 Jul; 41(1):25-32. PubMed ID: 17475575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
    Abdallah BM; Ditzel N; Mahmood A; Isa A; Traustadottir GA; Schilling AF; Ruiz-Hidalgo MJ; Laborda J; Amling M; Kassem M
    J Bone Miner Res; 2011 Jul; 26(7):1457-71. PubMed ID: 21308776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of runt-related transcription factor 2 (Runx2) in the late stage of odontoblast differentiation and dentin formation.
    Li S; Kong H; Yao N; Yu Q; Wang P; Lin Y; Wang J; Kuang R; Zhao X; Xu J; Zhu Q; Ni L
    Biochem Biophys Res Commun; 2011 Jul; 410(3):698-704. PubMed ID: 21703228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runx2 is a target of mechanical unloading to alter osteoblastic activity and bone formation in vivo.
    Salingcarnboriboon R; Tsuji K; Komori T; Nakashima K; Ezura Y; Noda M
    Endocrinology; 2006 May; 147(5):2296-305. PubMed ID: 16455780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JunD suppresses bone formation and contributes to low bone mass induced by estrogen depletion.
    Kawamata A; Izu Y; Yokoyama H; Amagasa T; Wagner EF; Nakashima K; Ezura Y; Hayata T; Noda M
    J Cell Biochem; 2008 Mar; 103(4):1037-45. PubMed ID: 18240141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation.
    Kodama N; Nagata M; Tabata Y; Ozeki M; Ninomiya T; Takagi R
    Bone; 2009 Apr; 44(4):699-707. PubMed ID: 19166987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Runx2: of bone and stretch.
    Ziros PG; Basdra EK; Papavassiliou AG
    Int J Biochem Cell Biol; 2008; 40(9):1659-63. PubMed ID: 17656144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of osteoblast differentiation by transcription factors.
    Komori T
    J Cell Biochem; 2006 Dec; 99(5):1233-9. PubMed ID: 16795049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Runx2 regulation and its isoforms.
    Li YL; Xiao ZS
    Med Hypotheses; 2007; 68(1):169-75. PubMed ID: 16901655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.